Researchers from the Agency for Science, Technology and Research (A*STAR) and the National Healthcare Group (NHG) have jointly pioneered an innovative imaging technique combining Multispectral ...

Researchers from the Agency for Science, Technology and Research (A*STAR) and the National Healthcare Group (NHG) have ...

Findings from a phase 1 trial demonstrate that silmitasertib shows potential for the treatment of patients with advanced ...

Senhwa Biosciences announces positive data from phase 1/expansion trial of Silmitasertib for basal cell carcinoma treatment: Taipei, Taiwan Thursday, April 3, 2025, 15:00 Hrs [IST ...

Century Therapeutics has joined the onslaught of cell therapy biotechs taking hits, discontinuing a phase 1 cancer study to turn its focus toward autoimmune diseases. The move isn’t shocking ...

Ultimately, it will help develop personalised therapy plans, highlighting specific changes that could be targeted in conditions such as cancer. Every cell in the human body communicates with its ...

Her type of cancer – clear cell ovarian cancer – is rare and particularly aggressive. She is only alive today because of her determination to access cutting-edge therapies as a result of her ...

Despite these challenges, Regeneron's other drugs, particularly Dupixent and Libtayo, show promise for ... 2012 to treat metastatic colorectal cancer (marketed as Zaltrap). Both were formed ...

Engineers turn skin cells directly into neurons for cell therapy Date: March 13, 2025 Source: Massachusetts Institute of Technology Summary: Researchers devised a process to convert a skin cell ...

The Business Research Company Updated 2025 Market Reports have released and offer essential trends and forecasts up to 2034. Early purchase is your competitive edge! LONDON, GREATER LONDON, UNITED KIN ...